FGF21 and cholestasis: We demonstrate that FGF21 could ameliorate cholestasis-induced liver injury and fibrosis and that NaB administration could prevent the progression of bile duct ligation (BDL)-induced liver fibrosis by boosting FGF21 signals and enhancing the host energy metabolism along with modulating the gut microbiota.